Sarcoidosis after treatment with interferon-α: A case series and review of the literature

Respiratory Medicine

Volumn 100, Issue 11, 2006, Pages 2063-2068

  Goldberg, Hilary J ^a   Fiedler, Douglas ^b   Webb, Amy ^b   Jagirdar, Jashiree ^b   Hoyumpa, Anastacio M ^b   Peters, Jay ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

Hepatitis; Interferon; Sarcoid

Indexed keywords

RECOMBINANT ALPHA INTERFERON; RIBAVIRIN;

ADULT; ARTICLE; BRONCHUS BIOPSY; CASE REPORT; CASE STUDY; COMPUTER ASSISTED TOMOGRAPHY; COUGHING; DRUG ERUPTION; DRUG WITHDRAWAL; DYSPNEA; FEMALE; FIBEROPTIC BRONCHOSCOPY; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LUNG FUNCTION TEST; LUNG INFILTRATE; LUNG SARCOIDOSIS; LYMPHADENOPATHY; MALE; PRIORITY JOURNAL; SUBCUTANEOUS NODULE; THORAX RADIOGRAPHY;

ADULT; ANTIVIRAL AGENTS; HEPATITIS C; HUMANS; INTERFERON TYPE I, RECOMBINANT; MALE; MIDDLE AGED; SARCOIDOSIS;

EID: 33749491825     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2006.03.004     Document Type: Article

References (52)

1. Husa P., Klusakova J., Jancikova J., Husova L., and Horalek F. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis B. Eur J Internal Med 13 (2002) 129-131
2. Wandl U.B., Kloke O., Nagel-Hiemke M., Moritz T., Becher R., Opalka B., et al. Combination therapy with interferon alpha-2b plus low-dose interferon gamma in pretreated patients with Ph-positive chronic myelogenous leukaemia. Br J Haematol 81 14 (1992) 516-519
3. Yavorkovsky L.L., Carrum G., Bruce S., and McCarthy P.L. Cutaneous sarcoidosis in a patient with Philadelphia-positive chronic myelogenous leukemia treated with interferon-alpha. Am J Hematol 58 1 (1998) 80-81
4. Kikawada M., Ichinose Y., Kunisawa A., Yanagisawa N., Minemura K., Kasuga I., et al. Sarcoidosis induced by interferon therapy for chronic myelogenous leukaemia. Respirology 3 1 (1998) 41-44
5. Schmuth M., Prior C., Illersperger B., Topar G., Fritsch P., and Sepp N. Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous?. Br J Dermatol 140 5 (1999) 952-955
6. Pietropaoli A., Modrak J., and Utell M. Interferon-alpha therapy associated with the development of sarcoidosis. Chest 117 1 (2000) 294
7. Fiorani C., Sacchi S., Bonacorsi G., and Cosenza M. Systemic sarcoidosis associated with interferon-alpha treatment for chronic myelogenous leukemia. Haematologica 85 9 (2000) 1006-1007
8. Frankova H., Gaja A., and Hejlova N. Pulmonary sarcoidosis in a patient with essential thrombocythemia treated with interferon alpha: a short case report. Med Sci Monitor 6 2 (2000) 380-382
9. Nakajima M., Kubota Y., Miyashita N., Niki Y., Matsushima T., and Manabe T. Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Internal Med 35 5 (1996) 376-379
10. Hunt J., Gordon F.D., Jenkins R.L., Lewis W.D., and Khettry U. Sarcoidosis with selective involvement of a second liver allograft: report of a case and review of the literature. Mod Pathol 12 3 (1999) 325-328 [Review; 12 Refs]
11. Li S.D., Yong S., Srinivas D., and Van Thiel D.H. Reactivation of sarcoidosis during interferon therapy. J Gastroenterol 37 1 (2002) 50-54
12. Leclerc S., Myers R., Moussalli J., Herson S., Poynard T., and Benveniste O. Sarcoidosis and interferon therapy: report of five cases and review of the literature. Eur J Internal Med 14 (2003) 237-243
13. Perez-Alvarez R., Perez-Lopez R., Lombrana J.L.S., Rodriguez M., and Rodrigo L. Sarcoidosis in two patients with chronic hepatitis C treated with interferon, ribavirin, and amantadine. J Viral Hepatitis 9 (2002) 75-79
14. Luchi S., and Scasso A. Sarcoidosis, chronic hepatitis C and interferon alpha: two cases. Scand J Infect Dis 35 (2003) 775-776
15. Ramos C., Manuel M., Juan N., Norma B., Pilar X., Antoni S., et al. Sarcoidosis in patients with chronic Hepatitis C virus infection: analysis of 68 cases article. Medicine 84 2 (2005) 69-80
16. Pohl J., Stremmel W., and Kallinowski B. Pulmonal sarcoidosis: a rare side effect of interferon-alpha treatment for chronic hepatitis C infection. Z Gastroenterol 38 12 (2000) 951-955
17. Cogrel O., Doutre M.S., Marliere V., BeylotBarry M., Couzigou P., and Beylot C. Cutaneous sarcoidosis during interferon alfa and ribavirin treatment of hepatitis C virus infection: two cases report. Br J Dermatol 146 2 (2002) 320-324
18. Werchniak A.E., Cheng S.X., Dhar A.D., and Klaus S.N. Sarcoidosis presenting as tattoo changes in a patient undergoing treatment with interferon-alpha and ribavirin. Clin Exp Dermatol 29 (2004) 545-562
19. Alfageme Michavila I., Merino Sanchez M., Perez Ronchel J., Lara Lara I., Suarez Garcia E., and Lopez Garrido J. Sarcoidosis following combined ribavirin and interferon therapy: a case report and review of the literature. Arch Bronconeumol 40 1 (2004) 45-49 [Review; 29 Refs]
20. Nawras A., Alsolaiman M.M., Mehboob S., Bartholomew C., and Maliakkal B. Systemic sarcoidosis presenting as a granulomatous tattoo reaction secondary to interferon-alpha treatment for chronic hepatitis C and review of the literature. Dig Dis Sci 47 7 (2002) 1627-1631
21. Neglia V., Sookoian S., Herrera M., Abeldano A., Kien M.C., Chouela E., et al. Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b. J Cutan Med Surgery 5 5 (2001) 406-408
22. Hoffman R.M., Jung M.C., Motz R., Gol C., Emslander H.P., Zachvol R., et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol 28 6 (1998) 1058-1063
23. Vander Els N.J., and Gerdes H. Sarcoidosis and IFN-alpha treatment. Chest 116 2 (1999) 569-572
24. Noguchi K., Enjoji M., Nakamuta M., Sugimoto R., Kotoh K., and Nawata H. Various sarcoid lesions in a patient induced by interferon therapy for chronic hepatitis C. J Clin Gastroenterol 35 3 (2002) 282-284
25. Menon Y., Cucurull E., Reisin E., and Espinoza L.R. Interferon-alpha-associated sarcoidosis responsive to infliximab therapy. Am J Med Sci 328 3 (2004) 173-175
26. Cacoub P., Sbai A., Frances C., Genesti C., Hausfater P., and Piette J.C. Systemic sarcoidosis during interferon-alpha therapy for chronic hepatitis C virus infection. Gastroenterol Clin Biol 24 3 (2000) 364-366
27. Teragawa H., Hondo T., Takahashi K., Watanabe H., Ohe H., Hattori N., et al. Sarcoidosis after interferon therapy for chronic active hepatitis C. Review 20 refs. Internal Med 35 1 (1996) 19-23
28. Papaioannides D., Fotinou M., Korantzopoulos P., Latsi P., Sinapidas D., Akritidis N., et al. Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. Med Sci Monitor 10 1 (2004) CS5-CS7
29. Marzouk K., Saleh S., Kannass M., and Sharma O.P. Interferon-induced granulomatous lung disease. Curr Opin Pulmon Med 10 5 (2004) 435-440 [Review 32 Refs]
30. Gitlin N. Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases. Eur J Gastroenterol Hepatol 14 8 (2002) 883-885
31. Tortorella C., Napoli N., Panella E., Antonaci A., Gentile A., and Antonaci S. Asymptomatic systemic sarcoidosis arising 5 years after IFN-alpha treatment for chronic hepatitis C: a new challenge for clinicians. J Interferon Cytokine Res 24 11 (2004) 655-658
32. Tahan V., Ozseker F., Guneylioglu D., Baran A., Ozaras R., Mert A., et al. Sarcoidosis after use of interferon for chronic hepatitis C. Dig Dis Sci 48 1 (2003) 169-173
33. Rubinowitz A.N., Naidich D.P., and Alinsonorin C. Interferon-induced Sarcoidosis. J Comput Assisted Tomogr 27 2 (2003) 279-283
34. Ravenel J.G., McAdams P., Plankeel J.F., Butnor K.J., and Sporn T.A. Sarcoidosis induced by interferon therapy. Am J Respirol 177 (2001) 199-201
35. Butnor K.J. Pulmonary sarcoidosis induced by interferon-alpha therapy. Am J Surg Pathol 29 7 (2005) 976-979
36. Wendling J., Descamps V., Grossin M., Marcellin P., Le Bozac P., Belaich S., et al. Sarcoidosis during combined interferon alpha and ribavirin therapy in 2 patients with chronic hepatitis C. Arch Dermatol 138 4 (2002) 546-547
37. Konig B., Hein R., Abeck D., Engst R., and Ring J. Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C. Br J Dermatol 140 (1999) 370-371
38. Ohhata I., Ochi T., Kurebayashi S., Masutani H., and Kikui M. A case of subcutaneous sarcoid nodules induced by interferon-alpha. Jpn J Thoracic Dis 32 10 (1994) 996-1000
39. Rogers C.J., Romagosa R., and Vincek V. Cutaneous sarcoidosis associated with pegylated interferon alpha and ribavirin therapy in a patient with chronic hepatitis C. J Acad Dermatol 50 4 (2004) 649-650
40. Akahoshi M., Ishihara M., Remus N., Uno K., Miyake K., Hirota T., et al. Association between IFNA genotype and the risk of sarcoidosis. Hum Genet 114 (2004) 503-509
41. Pinkston P., Bitterman P.B., and Crystal R.G. Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 308 14 (1983) 793-800
42. Shigehara K., Shijubo N., Ohmichi M., Takahashi R., Kon S., Okamura M., et al. IL-12 and IL-18 are increased and stimulate IFN-gamma production in sarcoid lungs. J Immunol 166 (2001) 642-649
43. Robinson B.W.S., McLemore T.L., and Crystal R.G. Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 75 (1985) 1488-1495
44. Agostini C., Trentin L., Perin A., Facco M., Siviero M., Piazza F., et al. Regulation of alveolar macrophage-T cell interactions during Th1-type sarcoid inflammatory process. Am J Physiol Lung Cellular Mol Physiol 277 (1999) L240-L250
45. Inui N., Chida K., Suda T., and Nakamura H. TH1/TH2 and TC1/TC2 profiles in peripheral blood and bronchoalveolar lavage fluid cells in pulmonary sarcoidosis. J Allergy Clin Immunol 107 (2001) 337-344
46. Wysoczanska B., Bogunia-Kubik K., Suchnicki K., Mlynarczewska A., and Lange A. Combined association between IFN-gamma 3,3 homozygosity and DRB1*03 in Lofgren's syndrome patients. Immunol Lett 91 (2004) 127-131
47. Yamaguchi S., Kubo K., Fujimoto K., Honda T., Sekiguchi M., and Sodeyama T. Analysis of bronchoalveolar lavage fluid in patients with chronic hepatitis C before and after treatment with interferon alpha. Thorax 52 33-7 (1997) 33-37
48. Abdi E.A., Nguyen G.K., Ludwig R.N., and Dickout W.J. Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59 5 (1987) 896-900
49. Mehta C.L., Tyler R.J., and Cripps D.J. Granulomatous dermatitis with focal sarcoidal features associated with recombinant interferon beta-1b injections. J Am Acad Dermatol 39 6 (1998) 1024-1028
50. Bobbio-Pallavicini E., Valsecchi C., Tacconi F., Moroni M., and Porta C. Sarcoidosis following beta-interferon therapy for multiple myeloma. Sarcoidosis 12 2 (1995) 140-142
51. Miwa H., Furuya T., Tanaka S., and Mizuno Y. Neurosarcoidosis associated with interferon therapy. Eur Neurol 45 4 (2001) 288-289
52. Raanani P., and Ben-Bassat I. Immune-mediated complications during interferon therapy in hematological patients. Acta Haematol 107 3 (2002) 133-144 [Review; 77 Refs]